OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells. [electronic resource]
Producer: 20170906Description: 5722-5734 p. digitalISSN:- 1476-5594
- Animals
- Antineoplastic Agents, Hormonal -- pharmacology
- Binding Sites
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation
- Cell Transformation, Neoplastic -- genetics
- Disease Models, Animal
- Drug Resistance, Neoplasm -- genetics
- Estrogen Receptor alpha -- metabolism
- Female
- Gene Expression
- Gene Expression Regulation, Neoplastic -- drug effects
- Gene Knockdown Techniques
- Homeodomain Proteins -- metabolism
- Humans
- Mice
- Models, Biological
- Nucleotide Motifs
- Octamer Transcription Factor-3 -- genetics
- Phosphorylation
- Protein Binding
- Response Elements
- S-Phase Kinase-Associated Proteins -- metabolism
- Signal Transduction
- Tamoxifen -- pharmacology
- Transcription Factors -- metabolism
- Xenograft Model Antitumor Assays
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.